Educational Seminars (Industry sponsored)

We are pleased to introduce our educational seminars co-sponsored by our industry partners as follows:

All educational seminars will be held during lunch time and lunch boxes will be provided to seminar audience.
An admission ticket (Educational Seminar Ticket) will be required to attend educational seminars.
Online reservation will be available in June for those who complete pre-registration.

  • * There is no additional cost to participate in these seminars. Tickets are limited and it is served on a first-come, first-served basis.

September 17, Thursday 12:45-14:00 (75mins)

Educational Seminar (ES-1) AstraZeneca K.K.

Title “The Forefront of Asthma Treatment Evolution -Mild to Severe Asthma-”
Chair 
Kazuto Matsunaga (Yamaguchi University Hospital, Yamaguchi, Japan)
Speakers 
Masayuki Hojo (Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan)
Norihiro Harada (Juntendo University, Tokyo, Japan)

Educational Seminar (ES-2) Mylan EPD G.K.

“Anaphylaxis in Practice with Clinical Cases -Up-to-date Information About Diagnosis, Treatment and Patient Education of Anaphylaxis-”
Chair 
Motohiro Ebisawa (Sagamihara National Hospital, Kanagawa, Japan)
Speakers 
“Diagnosis of Anaphylaxis based on Guidelines”
Antonella Muraro (Padua University Hospital, Padua, Italy)
“Importance of Continuing Treatment of Patient with a History of Anaphylaxis”
Margitta Worm (Charité - Universitätsmedizin Berlin, Germany)
“The Latest Patient Education to be Properly Ready for Anaphylaxis”
Sakura Sato (Sagamihara National Hospital, Kanagawa, Japan)

Educational Seminar (ES-3) GlaxoSmithKline K.K.

“Sever eosinophilic Asthma”
Chair 
Nobuyuki Hizawa (University of Tsukuba, Ibaraki, Japan)
Speaker 
TBA

Educational Seminar (ES-4) Novartis Pharma K.K.

Title “TBA”

Educational Seminar (ES-5) Sanofi K.K.

“Type 2 inflammation in Upper and Lower Airway”
Chair 
Akihito Yokoyama (Kochi University, Kochi, Japan)
Speakers 
“Chronic rhinosinusitis with nasal polyps: pathogenesis and new treatment approach”
Yuji Nakamaru (Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan)
“Pathophysiology and optimal treatment of adult severe asthma”
Masami Taniguchi (Shonan Kamakura General Hospital, Kanagawa, Japan)

Educational Seminar (ES-6) SYSMEX CORPORATION

“What is the best treatment strategy for Atopic Dermatitis?
-from Diagnostic to Treatment-“
Chair 
Masutaka Furue (Kyushu University, Fukuoka, Japan)
Speakers 
“Diagnosis and treatment of atopic dermatitis in China: progress of four decades”
Zhang Jianzhong (Peking University People's Hospital, Beijing, China)
“Advanced atopic dermatitis treatment by serum biomarker “TARC” guided precise medicine”
Yoko Kataoka (Osaka Habikino Medical Center, Osaka, Japan)

Educational Seminar (ES-7) Sanofi K.K.

“Refractory Chronic Rhinosinusitis ‘UP TO DATE’”
Chair 
Shigeharu Fujieda (University of Fukui, Fukui, Japan)
Speakers 
“Type 2 inflammation and its burden on chronic rhinosinusitis and nasal polyps”
Mitsuhiro Okano (International University of Health and Welfare Graduate School of Medicine, Tochigi, Japan)
“Steroid resistant rhinosinusitis -Closs Talk with Basic and Clinics-“
Nobuo Ota (Tohoku Medical and Pharmaceutical University, Miyagi, Japan)

Educational Seminar (ES-8) ALK-Abelló A/S

Title “TBA”

September 18, Friday 12:15-13:30 (75mins)

Educational Seminar (ES-9) Novartis Pharma K.K.

“How will treatment for moderate to severe asthma change?”
Chair 
Hiromasa Inoue (Graduate school of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan)
Speakers 
“Current situation and issues of management for moderate to severe asthma”
Kazuto Matsunaga (Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan)
“The future of moderate to severe asthma treatment”
Yasuhiro Gon (Nihon University, Tokyo, Japan)

Educational Seminar (ES-10) GlaxoSmithKline K.K.

“COPD”
Chair 
Ichiro Kuwahira (Japan)
Speakers 
Hisatoshi Sugiura (Japan)
Soichiro Hozawa (Japan)

Educational Seminar (ES-11) Takeda Pharmaceutical Company limited

“The evolution of HAE treatment: how to improve patient outcomes”
Chair 
Naoko Inomata (Yokohama City University Graduate School of Medicine, Kanagawa, Japan)
Speakers 
“Understanding the pathogenesis of HAE”
Naoko Inomata (Yokohama City University Graduate School of Medicine, Kanagawa, Japan)
“The burden of living with HAE”
Beverley Yamamoto (Graduate school of Human Sciences, Osaka University, Osaka, Japan / HAEJ / HAEi)
“Health-related quality of life in HAE”
Hilary Longhurst (Addenbrooke's Hospital / NHS Trust / Royal Nose, Ear & Throt Hospital UCLH, London, UK)
“Evolving treatment of HAE”
Marcus Maurer (Allergie-Center, Germanyum-Charite, Berlin, Germany)

Educational Seminar (ES-12) Thermo Fisher Scientific

“Clinical significance of fungal specific IgE testing in severe asthma and allergic bronchopulmonary aspergillosis (ABPA). (tentative)”
Chair 
Koichiro Asano (Tokai University School of Medicine, Kanagawa, Japan)
Speakers 
“Clinical practice guidance of allergic bronchopulmonary mycosis (ABPM) in Japan. (tentative)”
Koichiro Asano (Tokai University School of Medicine, Kanagawa, Japan)
“The importance of fungal specific IgE testing in allergic bronchopulmonary aspergillosis (ABPA). (tentative)”
Yuma Fukutomi (NHO Sagamihara National Hospital, Kanagawa, Japan)
“Clinical implications of fungal sensitization in severe asthma (tentative)”
Masami Taniguchi (Shonan Kamakura General Hospital, Kanagawa, Japan)

Educational Seminar (ES-13) Sanofi K.K.

“Skin barrier destruction in Atopic Dermatitis”
Chair 
Kenji Kabashima (Kyoto University Graduate School of Medicine, Kyoto, Japan)
Speakers 
“Therapeutic strategies of atopic dermatitis”
Saeko Nakajima (Kyoto University Graduate School of Medicine, Kyoto, Japan)
“(Draft) Recent developments and advances in atopic dermatitis”
Lisa A. Beck (University of Rochester Medical Center, USA)

Educational Seminar (ES-14) Torii Pharmaceutical Co., Ltd

“Sublingual immunotherapy”
Chair 
Sankei Nishima (National Hospital Organization Fukuoka Hospital, Fukuoka, Japan)
Speakers 
“Sublingual immunotherapy for allergic rhinitis in Japan”
Kimihiro Okubo (Nippon Medical School, Tokyo, Japan)
“Allergen immunotherapy in children”
Takao Fujisawa (Mie National Hospital, Mie, Japan)

September 19, Saturday 12:15-13:30 (75mins)

Educational Seminar (ES-15) Sanofi K.K.

“Treatment strategy of focus on IL-4/13 in severe asthma”
Chair 
Takeshi Kaneko (Yokohama City University Graduate School of Medicine, Kanagawa, Japan)
Speakers 
“Role of IL-4/13 in the pathogenesis of severe asthma”
Koichiro Matsumoto (Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
"(Draft) Update on clinical evidence for biologics in moderate to severe asthma"
Mario Castro (Washington University School of Medicine, USA)

Educational Seminar (ES-16) Novartis Pharma K.K.

Title “TBA”

Educational Seminar (ES-17) Maruho Co., Ltd.

“Mechanism and Treatment of Itch in Atopic dermatitis”
Chair 
Norito Katoh (Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan)
Speakers 
“The molecular and cellular bases of itch in atopic dermatitis”
Mitsutoshi Tominaga (Juntendo University Graduate School of Medicine Institute for Environmental and Gender Specific Medicine / Juntendo Itch Research Center, Tokyo, Japan)
“Itch of atopic dermatitis from the view point of Clinical, including the topics on European guideline and Protopic”
Andreas Wollenberg (Ludwig-Maximilians-University of Munich, Munich, Germany)

Educational Seminar (ES-18) Thermo Fisher Scientific

Title “TBA”

Educational Seminar (ES-19) Takeda Pharmaceutical Company limited

“Now is the time to define optimal early on-demand treatment for HAE patients”
Chair 
Michihiro Hide (Hiroshima University, Hiroshima, Japan)
Speakers 
Marcus Maurer (Charité - Universitätsmedizin Berlin, Berlin, Germany)
Hilary Longhurst (University College London Hospitals and Addenbrooke’s Hospital, Cambridge, UK)

Educational Seminar (ES-20) SHIONOGI & CO., LTD.

“House dust mite sublingual immunotherapy:
Current status in Japan and expectations for the future.(draft)”
Chair 
Yoshitaka Okamoto (Chiba Rousai Hospital, Chiba, Japan)
Speaker 
Mitsuhiro Okano (International University of Health and Welfare Graduate School of Medicine, Tochigi, Japan)

Educational Seminar (ES-21) AstraZeneca K.K.

“Update COPD treatment”
Chair 
Takahide Nagase (The University of Tokyo Hospital, Tokyo, Japan)
Speakers 
Yoko Shibata (Fukushima Medical University Hospital, Fukushima, Japan)
Koichiro Takahashi (Saga University Hospital, Saga, Japan)

Educational Seminar (ES-22) GlaxoSmithKline K.K.

“Asthma”
Chair 
Koichi Fukunaga (Keio University, School of Medicine, Tokyo, Japan)
Speakers 
Peter Daley-Yates (GlaxoSmithKline UK, UK)
Junpei Saito (Japan)

September 20, Sunday 12:15-13:15 (60mins)

Educational Seminar (ES-23) Sanofi K.K.

“Type2 inflammation in Allergic disease”
Chair 
Motohiro Ebisawa (Sagamihara National Hospital, Kanagawa, Japan)
Speakers 
“Pathophysiology and treatment of chronic rhinosinusitis ― up-to-date”
Kenji Kondo (Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)
“Role of IL-4/13 in the pathophysiology of asthma”
Toshiyuki Koya (Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
“Pathogenesis of atopic dermatitis in the context of cytokines :Long term clinical experience of Dupixent in the treatment of atopic dermatitis”
Yozo Ishiuji (Jikei University Tokyo, Tokyo, Japan)

Educational Seminar (ES-24) Mylan EPD G.K.

“Future Outlook of Food Allergy and Anaphylaxis Management”
Chair 
Yukihiro Ohya (National Center for Child Health and Development, Tokyo, Japan)
Speaker 
Takanori Imai (Showa University Hospital, Tokyo, Japan)

Educational Seminar (ES-25) Thermo Fisher Scientific

“Component-resolved diagnostics in food allergy practice”
Chair 
Yusei Ohshima (Faculty of Medical Sciences, University of Fukui, Fukui, Japan)
Speakers 
“Limitations of specific IgE antibody test and component-resolved diagnostics”
Mizuho Nagao (National Hospital Organization Mie National Hospital, Mie, Japan)
“Approach to special type food allergy diagnosis”
Naoko Inomata (Yokohama City University Graduate School of Medicine, Yokohama, Japan)

Educational Seminar (ES-26) KYORIN Pharmaceutical Co. Ltd.

“Reconsider inhalation therapy in asthma ~ the benefits of using aerosol device~”
Chair 
Yuji Tohda (KINDAI University Hospital, Osaka, Japan)
Speakers 
“Reconsider the benefits of inhaled corticosteroid treatment using a metered dose inhaler”
Hisako Matsumoto (Graduate School of Medicine, Kyoto University, Kyoto, Japan)
“What are more beneficial inhalation medications and devices for patients with asthma”
Hiroyuki Ohbayashi (Tohno-Chuo Clinic, Gifu, Japan)

Educational Seminar (ES-27) Santen Pharmaceutical Co., Ltd./Mitsubishi Tanabe Pharma Corporation

“Current status and issues of allergic conjunctival disease in Japan:
epidemiology , pathophysiology , medical examination”
Chair 
Nobuyuki Ebihara (Juntendo University Urayasu Hospital, Chiba, Japan)
Speakers 
“Classification and epidemiology of allergic conjunctival diseases in Japan”
Dai Miyazaki (Tottori University, Tottori, Japan)
“Characteristics of allergic conjunctival diseases in Japan”
Jun Shoji (Nihon University School of Medicine, Tokyo, Japan)
“Medical treatment of allergic conjunctival disease”
Atsuki Fukushima (Kochi Medical School, Kochi, Japan)
“Effects of the compliance of anti‐histamine ophthalmic solutions on Quality of Life in patients with seasonal allergic conjunctivitis using web questionnaire”
Kazumi Fukagawa (Ryogoku Eye Clinic, Tokyo, Japan)

Educational Seminar (ES-28) Hisamitsu Pharmaceutical Co., Inc.

“Pitfall of diagnosis & treatment for Allergic Rhinitis, CRS. - What is Plan B?”
Chair 
Daiju Sakurai (School of Medicine, University of Yamanashi, Yamanashi, Japan)
Speaker 
Mikiya Asako (Kansai Medical University Medical Center, Osaka, Japan)